Anja Pickhard1, Simone Gröber2, Anna Katharina Haug2, Guido Piontek2, Markus Wirth2, Ulrich Straßen2, Martina Rudelius3, Rudolf Reiter4. 1. Department of Otolaryngology-Head and Neck Surgery, Technical University of Munich, Munich, Germany. Electronic address: a.pickhard@lrz.tum.de. 2. Department of Otolaryngology-Head and Neck Surgery, Technical University of Munich, Munich, Germany. 3. Department of Pathology, Technical University of Munich, Munich, Germany. 4. Department of Otolaryngology-Head and Neck Surgery, Section of Phoniatrics and Pedaudiology, University of Ulm, Ulm, Germany.
Abstract
OBJECTIVE: The purpose of our study was to investigate the expression patterns of cell cycle regulatory proteins and members of the epidermal growth factor receptor (EGFR) signaling pathway in squamous cell carcinoma of the head and neck (HNSCC). STUDY DESIGN: The expression levels of survivin, Bub1 B (budding uninhibited by benzimidazoles 1 homolog beta), PLK-1 (polo-like kinase 1), Ki-67, cyclin D1, p53, EGFR, pMAPK (phosphorylated mitogen-activated protein kinase), pAkt (phosphorylated protein kinase B), and PTEN (phosphatase and tensin homolog) were studied in a series of 180 tumor samples obtained from HNSCC surgical resections, 50 metastatic lymph node samples, and 72 corresponding noncancerous epithelium samples. Protein expression analysis was performed by immunohistochemical staining. The results were correlated with clinicopathologic features and survival data. RESULTS: Prognostic significance could be found only for the markers survivin and pAkt. Only the marker combination of cyclin D1 and p53 had positive prognosis potential regarding overall survival. CONCLUSIONS: Both pAkt and survivin show a positive correlation with distant metastases and may have utility as predictors of long-term outcomes for patients with HNSCC.
OBJECTIVE: The purpose of our study was to investigate the expression patterns of cell cycle regulatory proteins and members of the epidermal growth factor receptor (EGFR) signaling pathway in squamous cell carcinoma of the head and neck (HNSCC). STUDY DESIGN: The expression levels of survivin, Bub1 B (budding uninhibited by benzimidazoles 1 homolog beta), PLK-1 (polo-like kinase 1), Ki-67, cyclin D1, p53, EGFR, pMAPK (phosphorylated mitogen-activated protein kinase), pAkt (phosphorylated protein kinase B), and PTEN (phosphatase and tensin homolog) were studied in a series of 180 tumor samples obtained from HNSCC surgical resections, 50 metastatic lymph node samples, and 72 corresponding noncancerous epithelium samples. Protein expression analysis was performed by immunohistochemical staining. The results were correlated with clinicopathologic features and survival data. RESULTS: Prognostic significance could be found only for the markers survivin and pAkt. Only the marker combination of cyclin D1 and p53 had positive prognosis potential regarding overall survival. CONCLUSIONS: Both pAkt and survivin show a positive correlation with distant metastases and may have utility as predictors of long-term outcomes for patients with HNSCC.
Authors: Murat Doğan; Sedat Çağlı; İmdat Yüce; Ali Bayram; Mehmet Akif Somdaş; Duran Karataş; Mehmet Celalettin Cihan; Fatih Yüksel; Ercihan Güney Journal: Eur Arch Otorhinolaryngol Date: 2014-03-28 Impact factor: 2.503
Authors: Paola Fernandes Pansini; Isabella Bittencourt do Valle; Thabata Coeli Dias Damasceno; Priscila Marinho de Abreu; Anna Clara Gregório Có; Rossana Verónica Mendoza López; Jeferson Lenzi; Ricardo Mai Rocha; Evandro Duccini Souza; Maria Paula Curado; Hisham Mehanna; Paul Nankivell; José Roberto Vasconcelos de Podestá; Sandra Ventorin von Zeidler Journal: Head Neck Pathol Date: 2021-04-11
Authors: Anna Maria S Buchberger; Alexander Baumann; Guido Piontek; Dominik Schüttler; Martina Rudelius; Rudolf Reiter; Lena Gebel; Gerhard Piendl; Gero Brockhoff; Anja Pickhard Journal: Oncotarget Date: 2018-01-30
Authors: Salvatore Alfieri; Andrea Carenzo; Francesca Platini; Mara S Serafini; Federica Perrone; Donata Galbiati; Andrea P Sponghini; Roberta Depenni; Andrea Vingiani; Pasquale Quattrone; Edoardo Marchesi; Maria F Iannó; Arianna Micali; Elisa Mancinelli; Ester Orlandi; Sara Marceglia; Laura D Locati; Lisa Licitra; Paolo Bossi; Loris De Cecco Journal: Cancers (Basel) Date: 2020-04-09 Impact factor: 6.639